secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001140361-23-024283
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q1 revenue up 18% to $3.8M; operating loss flat at $2.0M
-----------------------------------------------------------------

- Revenue $3.8M (+18% YoY) within prior guidance; gross margin fell to 67% from 72%.
- UltraMist systems sold 28 (+12% YoY); applicator cases 3,641 (+18% YoY).
- Operating loss $2.0M, unchanged YoY; no net income/(loss) figure disclosed.
- Post-quarter raised ~$1.2M via terms consistent with prior financing; funds not in Q1 statements.
- Q2 revenue growth guided to 15-25% YoY, citing improving inventory supply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123024283/0001140361-23-024283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123024283/brhc20052858_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-024283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer